UNSPSC 51111639: Fazarabine

This classification denotes a pyrimidine antagonist with the molecular formula C8H12N4O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5V71D8JOKK, chemically known as 1,3,5-triazin-2 (1h)-one, 4-amino-1-.beta.-d-ribofuranosyl- but generally known as fazarabine, which bears US NIH Compound Identifier 1805. European Medicines Agency schedules Fazarabine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07517MIG.

UNSPSC 51111639 Fazarabine is a Commodity code covering procurement of this specific antineoplastic pharmaceutical agent. The source provides no recent state and local contract opportunities under this code. Without posted solicitations identifying actual purchasing patterns, issuing bodies, or geographic activity, no concrete framing of current buying behavior can be established from available records.

State and local procurement of specialized pharmaceuticals like fazarabine typically flows through established group purchasing organizations, state health department formularies, and institutional pharmacy networks rather than competitive solicitation channels that surface in public notice databases. The absence of recent RFP, RFQ, IFB, or ITB activity under this specific code does not indicate zero demand — it reflects the procurement methods commonly used for controlled pharmaceutical inventories in the public health system.